Face 2012 eye1
-
Upload
patrick-treacy -
Category
Health & Medicine
-
view
91 -
download
1
Transcript of Face 2012 eye1
![Page 1: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/1.jpg)
Periorbital Rejuvenation
The DUBLiN Method
Dr. Patrick J. TreacyMedical DirectorAilesbury Clinics Ltd
![Page 2: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/2.jpg)
The DUBLiN method uses different methods and technologies in order to activate fibroblasts and direct them towards neocollogenesis. It also uses low level pulsed lasers to reduce skin laxity, accelerate growth factors and cause tightening.
![Page 3: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/3.jpg)
The DUBLiN method incorporates
D Dermaroller
U Ultrapulse Laser
B Blood Factors
Li Light – 633nm
N Neurotoxin
![Page 4: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/4.jpg)
PERIORBITAL AGEING
Periorbital region is a immediate barometer of a patient’s chronological and environmental age. It tells its own history of ultraviolet light exposure and wish for aesthetic treatments
![Page 5: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/5.jpg)
PERIORBITAL AGEING
Anatomical changes include laxity of the eyelid skin, prominent infra-orbital fat pads, hypertrophic orbicularis oculi muscle, and even descent of the forehead, eyebrows and mid-face
![Page 6: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/6.jpg)
PERIORBITAL AGEING
Clinically photo-aged skin is wrinkled, blotchy and leathery. Eyelid laxity can cause both ectropion and entropion or eiphoria and laxity of the medial and lateral canthal tendon.
![Page 7: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/7.jpg)
PERIORBITAL AGEING
A variety of dermatological treatments are available such as topical creams, neurotoxin, RioBlush © carboxytherapy, Polaris © RF-radiofrequency and SmartXide © and AFX © CO2 fractionalised resurfacing lasers.
![Page 8: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/8.jpg)
TACTILEROUGHNESS
TACTILEROUGHNESS
SALLOW SKINSALLOW SKIN COARSE
RHYTIDS
COARSE RHYTIDS
FINE RYTHIDS
FINE RYTHIDS
THREAD VEINSTHREAD VEINS PIGMENTATION
PIGMENTATION
TitleTitlePHOTOAGEING
![Page 9: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/9.jpg)
WRINKLESWRINKLES
ECTROPION ECTROPION ENTROPION
ENTROPION
FATPROTRUSION
FATPROTRUSION
EPIPHORIA EPIPHORIA SKIN LAXITY
SKIN LAXITY
TitleTitleAGEING
![Page 10: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/10.jpg)
FAT PROTRUSION
FAT PROTRUSION
SALLOW SKINSALLOW SKIN THREAD VEINS
THREAD VEINS
COARSE RYTHIDS
COARSE RYTHIDS
FINERHYTIDS
FINERHYTIDS
PIGMENTATIONPIGMENTATION
TitleTitleLASER
![Page 11: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/11.jpg)
WRINKLESWRINKLES
TEAR TROUGH TEAR TROUGH WRINKLES
WRINKLES
FATPROTRUSION
FATPROTRUSION
PIGMENTATION PIGMENTATION SKIN LAXITY
SKIN LAXITY
TitleTitleCOLLAGEN
![Page 12: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/12.jpg)
Keratinocyte GF Keratinocyte GF
Vascular Endothelial GFVascular Endothelial GF Fibroblast GF
Fibroblast GF
Transforming GF-BTransforming GF-B
Connective Tissue GF Connective Tissue GF
Platelet Derived GFPlatelet Derived GF
TitleTitleCOLLAGEN
![Page 13: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/13.jpg)
Tissue Repair -FIBROBLASTS
A fibroblast is a type of cell that synthesizes the extracellular matrix and collagen, the structural framework (stroma) for animal tissues, and plays a critical role in wound healing. Fibroblasts are the most common cells of connective
tissue in animals.
![Page 14: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/14.jpg)
Tissue Repair -FIBROBLASTS
The efficacy of certain growth factors in forming collagen and healing various injuries is the theoretical basis for the use of PRP in tissue repair. The platelets collected in PRP are activated by the addition of thrombin and calcium chloride. This induces the release of these factors from alpha granules.
![Page 15: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/15.jpg)
DERMAROLLER
![Page 16: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/16.jpg)
LiGHT 633nm
Migrating cells exert forces against the substrate to move forward. These forces are part of the contraction phase of migration in which the rear of the cell is detached from the substrate and the body of the cell is moved forward.
![Page 17: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/17.jpg)
Near Red Light 633Near Red Light 633
Dermaroller Dermaroller
TitleTitleFibroblast Activation
PHASE 1
PRP Growth Factor Signals
![Page 18: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/18.jpg)
Mouse fibroblasts are starved for serum factors like PDF and IGF-1. Then, serum is added back and time lapse inverted phase contrast images are taken every 1 sec. Watch the ears of a cell, at the tips of a thin blanket of cytoplasm called "lamellipodium".
Blood Growth Factors
![Page 19: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/19.jpg)
Keratinocyte GF Keratinocyte GF
Vascular Endothelial GFVascular Endothelial GF Fibroblast GF
Fibroblast GF
Transforming GF-BTransforming GF-B
Connective Tissue GF Connective Tissue GF
Platelet Derived GFPlatelet Derived GF
TitleTitleCOLLAGEN
![Page 20: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/20.jpg)
Near Red Light 633Near Red Light 633
Low level Laser Low level Laser
TitleTitleFibroblast Activation
PHASE 2
AGERA Prolifersyn ®
![Page 21: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/21.jpg)
LOW LEVEL LASER
Laser specialists non-sequential fractionalised CO2 laser ablation is the most effective modality for repairing photo damaged skin
The benefits are more precise control of ablation depth, faster recovery time and reduced risk of post procedural problems
![Page 22: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/22.jpg)
Continuous vs Ultrapulse
Comparative Split Face Study
![Page 23: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/23.jpg)
Perioral split face study showing the different skin eschar results from the two fractionalised lasers immediately after treatment
![Page 24: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/24.jpg)
ULTRAPULSE
![Page 25: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/25.jpg)
Objective
Methods
Results
Conclusion
11
22
33
44 Conclusions
![Page 26: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/26.jpg)
![Page 27: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/27.jpg)
![Page 28: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/28.jpg)
![Page 29: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/29.jpg)
![Page 30: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/30.jpg)
![Page 31: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/31.jpg)
• A clinical assessment of each patient regarding the overall level of photoageing was made initially and at 2 weeks, I month and 3 months postoperatively in the presence of two physicians.
• Positive scoring was based on the degree of re-epithelialisation rate, reduction of rhytides, loss of hyperpigmentation and telangectasias and reduction of tactile roughness.
• The prolongation and severity of erythema as well as the presence of negative side effects (such as herpes were also recorded by both the patient and the doctor). The degree of photoageing and the efficacy of treatment were evaluated using a five-point scale originally suggested . by Dover et al.
![Page 32: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/32.jpg)
Score 0 1 2 3 4
Fine Lines None Rare Several Moderate Many
Pigment None Patchy Moderate Heavy Severe
Facial Veins None Rare Several Heavy Severe
Coarse Lines None Rare Several Moderate Many
Efficacy of treatment + scoring system
![Page 33: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/33.jpg)
Score 0 1 2 3 4
Touch Even Rare Mild Moderate Severe
Complexion Pink Pale Grey
Partial
Yellow
Grey
Distinct
Yellow
Grey
Efficacy of treatment + scoring system
![Page 34: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/34.jpg)
prolonged postoperative
recovery
pigmentary changes
erythema
infection
Although, ultrapulsed CO2 laser skin resurfacing was largely considered the best option for treatment of this type of photoaged facial skin, it also had certain
post- procedural problems
![Page 35: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/35.jpg)
Score 0 1 2 3 4
Erythema None Rare Several Moderate Severe
Crusting None Rare Several Moderate Severe
Pain None Rare Several Moderate Severe
Herpes None Rare Several Moderate Severe
Efficacy of treatment - scoring system
![Page 36: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/36.jpg)
5 daysImmediate
Random
![Page 37: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/37.jpg)
Your Text here Your Text hereYour Text hereMETHOD
• If the patient has a strong history of HSV, we initially prescribed Famvir (Famciclovir) 750mgs daily for 10 days or Valtrex (valcyclovir) 500 mg bd for 10 days starting three days before surgery. This was adjusted during the study to commence one week before and to be used for one week after.
• If the patient has a strong history of acne, we prescribe an antibiotic ByMycin (Doxycycline 100mgs daily) Augmentin Duo, (Amoxil Clavulinic Acid) Keflex (Cephalexin 500 mg bd) for 7 days, starting the day of surgery).
• If the patient has a strong history of frequent yeast infections, we prescribe Diflucan (Fluconazole 150mgs), starting on the 4th post-operative day and taken once orally every other day
PROHPYLAXIS
![Page 38: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/38.jpg)
Your Text here Your Text hereYour Text hereMETHOD
Topical Anaesthesia
Anestop® : (Amethocaine; Propitocaine; Lignocaine) as topical anaesthetic to the entire facial area for 45mins. Astra Zeneca Regional Anaesthesia Typically, we gave regional anaesthesia during the procedure including •Supraorbital and Supratrochlear Nerve Block•Infraorbital Nerve Block •Mental Nerve Block
ANAESTHESIA
![Page 39: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/39.jpg)
BiopsyBiopsy StainingStaining HistologyHistology
Histology was performed to determine the amount of tissue ablation, residual thermal damage, inflammation and neocollagenesis
Histology was performed to determine the amount of tissue ablation, residual thermal damage, inflammation and neocollagenesis
Lesion penetrative dimensions were assessed histologically using haematoxylin & eosin
Lesion penetrative dimensions were assessed histologically using haematoxylin & eosin
Skin biopsies were obtained from 5 patients intraoperatively from each side, after one laser pass, and at 3 months postop.
Skin biopsies were obtained from 5 patients intraoperatively from each side, after one laser pass, and at 3 months postop.
![Page 40: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/40.jpg)
Thermal effect at 100 µm seen histologically using haematoxylin & eosin
© Patrick Treacy
![Page 41: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/41.jpg)
3 months post © Patrick Treacy
![Page 42: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/42.jpg)
• Patient CM : Right Eye SmartXide treated (Power) 30W Dot Mode Spacing 200 μm Scanning well Time 500 μS 2 passes under R eye with obvious reduction in rhytides and neocollagenesis
![Page 43: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/43.jpg)
![Page 44: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/44.jpg)
• The two CO2 lasers (Lumenis ActiveFx Deka SmartXide) appeared to produce equivalent clinical improvement of lesions and rhytides. Re-epithelialisation occurred in all laser treated areas by both devices by day 7and this appeared to be similar for both lasers. Mean duration of reepithelialisation was 6.9 days after resurfacing (range, 4-10 days).
• Residual erythema remained for a period of 14 days but this was minimal (mean decreased from 4.1 on day 3 to 0.9 at day 14). Postoperative erythema was most intense in the areas treated by SmartXide whenever the dwell time was increased up to 1ms. This effect was also noted with the ActiveFx at the energy level above 125Mj.
RESULTS
![Page 45: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/45.jpg)
• All skin biopsies in this study show effect of thermal treatment with thermal coagulation of epidermis and superficial dermis in a depth ranging from 85 to 113 microns. This was similar in both lasers with the SmartXide consistently getting below 100 µm. Many studies show the zone of residual thermal (coagulative) damage can extend a further 20 to 120 µm, depending on the particular laser variables used
![Page 46: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/46.jpg)
![Page 47: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/47.jpg)
This was particularly evident in Patient C where the thermal effect appears to be more diffuse than focal and the evidence of effect was still measured at 700 microns, although this reflected a vague diffuse thermal effect as compared with the more localized usual effect. Because the various CO2 lasers currently available differ in their biophysical properties, their documented depth of histological ablation and thermal effects vary
BIOPSY
Patient C
![Page 48: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/48.jpg)
• The global score for photoageing for both devices improved from 13.8 at baseline to 9.6 at Day 30. The score for fine lines was the most significant reduction dropping form 3.6 at baseline to 1.4 at Day 30. The score for sallowness was the most difficult to interpret at Day 30 as the patients still had some mild erythematous effect. Scores for reduction of coarse wrinkles (3.2 at baseline to 2.2 at Day 30) was also difficult to interpret in this heterogeneous age grouping with older patients requiring the deeper penetrating ‘harder’ MaxFx rather than the ‘softer’ ActiveFx and it is apparent that Lumenis are presently working on a combination therapy to solve this problem.
RESULTS
![Page 49: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/49.jpg)
• If fractionalised laser skin resurfacing (FLSR) with minimal downtime is now considered the new method of softly treating patients for minor skin conditions such photoageing then the SmartXide DOT has cost advantages to the operator. It has yet to be established whether this will be in multiple sessions or not. If the physician requires to treat patients with deeper facial rhytides or other pathology in a one off session then the ActiveFx appears to have these advantages.
CONCLUSION
![Page 50: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/50.jpg)
![Page 51: Face 2012 eye1](https://reader035.fdocuments.us/reader035/viewer/2022062404/554ae597b4c905a37c8b50cb/html5/thumbnails/51.jpg)
www.ailesburyclinic.ie